ROCHESTER, N.Y., Sept. 18, 2024 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company […]
Singapore, Sept. 18, 2024 (GLOBE NEWSWIRE) — Orangekloud Technology Inc. (Nasdaq: ORKT) (“Orangekloud” or “the Company”), a Singapore-based technology company […]